Get the app
USHealthcare

The Oncology Institute, Inc. (STLN)

US · Healthcare · Medical Care Facilities

$6.63+1.53%
Last close · 2026-09-17

Latest quarter · ended 2026-06-30

Revenue
$161.3M
Revenue YoY
+34.6%
Net profit
$-9.8M
EPS
$-0.08
EPS estimate
$-0.07
Net margin
-6.1%

EPS came in at -0.08 against a street estimate of -0.07 — a miss of 14.3%.

Key statistics

Market cap
$664.5M
Forward P/E
0.0
P/B
0.76
Book value
$-0.25
EPS (TTM)
$-0.29
52-week high
$7.05
52-week low
$2.32
50-day MA
$5.84
200-day MA
$4.18
Beta
0.44

Analyst view

with an average price target of $9.00.

Shareholding

Insiders
17.79%
Institutions
46.74%

Largest institutional holders

FundStake
BlackRock Inc4.33%
Vanguard Capital Management, LLC3.41%
Deerfield Management Co3.30%
JOSH ARNOLD INVESTMENT CONSULTANT, LLC2.42%
Balyasny Asset Management LLC1.79%
Geode Capital Management, LLC1.72%
Wexford Capital LP1.68%
State Street Corp1.43%

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for The Oncology Institute, Inc. — free to start.

Google PlayApp Store

Other Healthcare companies

Data updated 2026-09-18.